...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New SEDAR page
Reply New Message
Prev Message Back To Forum Threaded View Next Message

"Distributions as reported in these past months to get it done on time if that is the main reason"

Well no response from IR yet. Probably putting together their creative juices looking for a response.

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply